S&P 500   3,849.62 (-0.15%)
DOW   30,937.04 (-0.07%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
S&P 500   3,849.62 (-0.15%)
DOW   30,937.04 (-0.07%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
S&P 500   3,849.62 (-0.15%)
DOW   30,937.04 (-0.07%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
S&P 500   3,849.62 (-0.15%)
DOW   30,937.04 (-0.07%)
QQQ   328.59 (+0.15%)
AAPL   143.16 (+0.17%)
MSFT   232.33 (+1.22%)
FB   282.05 (+1.45%)
GOOGL   1,907.95 (+0.72%)
AMZN   3,326.13 (+0.98%)
TSLA   883.09 (+0.26%)
NVDA   537.41 (-1.60%)
BABA   265.92 (+1.74%)
CGC   35.52 (+7.93%)
GE   11.29 (+2.73%)
MU   79.51 (-2.18%)
AMD   94.71 (+0.62%)
NIO   60.31 (+0.53%)
T   29.75 (+2.20%)
F   11.19 (-0.89%)
ACB   10.67 (+5.02%)
BA   202.06 (-0.64%)
DIS   169.56 (-1.36%)
NFLX   561.93 (+0.92%)
GILD   66.70 (-2.14%)
Log in

Marathon Oil (NYSE:MRO) Stock Rating Upgraded by Siebert Williams Shank

Last updated on Friday, January 22, 2021 | 2021 MarketBeat

Marathon Oil (NYSE:MRO) was upgraded by Siebert Williams Shank from a "hold" rating to a "buy" rating in a note issued to investors on Friday, Briefing.com reports.

MRO has been the topic of several other research reports. Citigroup lowered their target price on shares of Marathon Oil from $6.50 to $4.75 and set a "neutral" rating on the stock in a report on Wednesday, October 14th. Morgan Stanley lifted their target price on shares of Marathon Oil from $5.00 to $7.00 and gave the company an "underweight" rating in a report on Friday, December 11th. Smith Barney Citigroup lifted their target price on shares of Marathon Oil from $6.00 to $9.00 in a report on Wednesday, January 13th. Barclays raised shares of Marathon Oil from an "equal weight" rating to an "overweight" rating in a report on Thursday, January 14th. Finally, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell lifted their target price on shares of Marathon Oil from $6.00 to $9.00 in a report on Wednesday, January 13th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and ten have given a buy rating to the company's stock. The company has a consensus rating of "Hold" and a consensus price target of $8.01.

NYSE MRO opened at $8.25 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.18 and a current ratio of 1.23. The firm has a market cap of $6.51 billion, a PE ratio of -5.73 and a beta of 3.36. Marathon Oil has a one year low of $3.02 and a one year high of $12.83. The firm's fifty day moving average is $7.19 and its two-hundred day moving average is $5.57.

Marathon Oil (NYSE:MRO) last posted its quarterly earnings data on Monday, November 9th. The oil and gas producer reported ($0.28) EPS for the quarter, meeting analysts' consensus estimates of ($0.28). The company had revenue of $754.00 million for the quarter, compared to analyst estimates of $762.20 million. Marathon Oil had a negative net margin of 32.64% and a negative return on equity of 6.64%. Marathon Oil's quarterly revenue was down 43.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.14 earnings per share. Research analysts predict that Marathon Oil will post -1.26 earnings per share for the current year.

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Capital Square LLC lifted its holdings in shares of Marathon Oil by 5.3% in the third quarter. Capital Square LLC now owns 40,010 shares of the oil and gas producer's stock valued at $163,000 after purchasing an additional 2,000 shares in the last quarter. Advisory Resource Group lifted its holdings in shares of Marathon Oil by 3.7% in the third quarter. Advisory Resource Group now owns 58,078 shares of the oil and gas producer's stock valued at $238,000 after purchasing an additional 2,054 shares in the last quarter. Fifth Third Bancorp lifted its holdings in shares of Marathon Oil by 6.4% in the third quarter. Fifth Third Bancorp now owns 39,284 shares of the oil and gas producer's stock valued at $161,000 after purchasing an additional 2,371 shares in the last quarter. Raymond James Trust N.A. lifted its holdings in shares of Marathon Oil by 14.9% in the third quarter. Raymond James Trust N.A. now owns 18,640 shares of the oil and gas producer's stock valued at $76,000 after purchasing an additional 2,424 shares in the last quarter. Finally, LPL Financial LLC lifted its holdings in shares of Marathon Oil by 1.4% in the third quarter. LPL Financial LLC now owns 214,382 shares of the oil and gas producer's stock valued at $877,000 after purchasing an additional 2,983 shares in the last quarter. 67.11% of the stock is currently owned by institutional investors.

Marathon Oil Company Profile

Marathon Oil Corporation operates as an independent exploration and production company in the United States and Equatorial Guinea. The company engages in the exploration, production, and marketing of crude oil and condensate, natural gas liquids, and natural gas; and the production and marketing of products manufactured from natural gas, such as liquefied natural gas and methanol, as well as owns and operates 32 central gathering and treating facilities and the Sugarloaf gathering system, a 42-mile natural gas pipeline through Karnes and Atascosa Counties.

Further Reading: Which market index is the best?

Analyst Recommendations for Marathon Oil (NYSE:MRO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]


15 Healthcare Stocks that Analysts Love

There are more than 200 healthcare companies traded on public markets. Given the sheer number of pharmaceutical companies, medical research firms, hospital systems, and other healthcare stocks, it can be hard to identify which healthcare companies will outperform the market.

Fortunately, Wall Street's brightest minds have already done this for us. Every year, analysts issue approximately 3,000 distinct recommendations for healthcare companies. Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when several analysts from different brokerages and research firms are giving "strong-buy" and "buy" ratings to the same healthcare stock.

This slide show lists the 15 healthcare companies with the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.

View the "15 Healthcare Stocks that Analysts Love".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.